Literature DB >> 22588055

Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis.

Ombretta Salvucci1, Giovanna Tosato.   

Abstract

Eph receptor tyrosine kinases and their Ephrin ligands represent an important signaling system with widespread roles in cell physiology and disease. Receptors and ligands in this family are anchored to the cell surface; thus Eph/Ephrin interactions mainly occur at sites of cell-to-cell contact. EphB4 and EphrinB2 are the Eph/Ephrin molecules that play essential roles in vascular development and postnatal angiogenesis. Analysis of expression patterns and function has linked EphB4/EphrinB2 to endothelial cell growth, survival, migration, assembly, and angiogenesis. Signaling from these molecules is complex, with the potential for being bidirectional, emanating both from the Eph receptors (forward signaling) and from the Ephrin ligands (reverse signaling). In this review, we describe recent advances on the roles of EphB/EphrinB protein family in endothelial cell function and outline potential approaches to inhibit pathological angiogenesis based on this understanding.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22588055      PMCID: PMC3500853          DOI: 10.1016/B978-0-12-386503-8.00002-8

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  177 in total

1.  EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.

Authors:  Ralf Erber; Uta Eichelsbacher; Violetta Powajbo; Tobias Korn; Valentin Djonov; Jihong Lin; Hans-Peter Hammes; Rainer Grobholz; Axel Ullrich; Peter Vajkoczy
Journal:  EMBO J       Date:  2006-01-19       Impact factor: 11.598

2.  EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures.

Authors:  Ombretta Salvucci; Dragan Maric; Matina Economopoulou; Shuhei Sakakibara; Simone Merlin; Antonia Follenzi; Giovanna Tosato
Journal:  Blood       Date:  2009-05-01       Impact factor: 22.113

3.  The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade.

Authors:  Jeffrey S Scehnet; Eric J Ley; Valery Krasnoperov; Ren Liu; Parmeet K Manchanda; Eric Sjoberg; Anna P Kostecke; Sachin Gupta; S Ram Kumar; Parkash S Gill
Journal:  Blood       Date:  2008-10-03       Impact factor: 22.113

4.  EphrinA1 inactivates integrin-mediated vascular smooth muscle cell spreading via the Rac/PAK pathway.

Authors:  Christophe Deroanne; Valérie Vouret-Craviari; Bingcheng Wang; Jacques Pouysségur
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

5.  EphA4-mediated Rho activation via Vsm-RhoGEF expressed specifically in vascular smooth muscle cells.

Authors:  Hisakazu Ogita; Satoshi Kunimoto; Yuji Kamioka; Hirofumi Sawa; Michitaka Masuda; Naoki Mochizuki
Journal:  Circ Res       Date:  2003-05-29       Impact factor: 17.367

6.  Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells.

Authors:  N W Gale; P Baluk; L Pan; M Kwan; J Holash; T M DeChiara; D M McDonald; G D Yancopoulos
Journal:  Dev Biol       Date:  2001-02-15       Impact factor: 3.582

7.  Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development.

Authors:  Chad A Cowan; Nobuhiko Yokoyama; Ankur Saxena; Michael J Chumley; Robert E Silvany; Linda A Baker; Deepak Srivastava; Mark Henkemeyer
Journal:  Dev Biol       Date:  2004-07-15       Impact factor: 3.582

8.  Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

Authors:  H U Wang; Z F Chen; D J Anderson
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

9.  Humanized anti-EphB4 antibodies for the treatment of carcinomas and vasculogenesis-related diseases.

Authors:  Zenghui Xu; Huajun Jin; Qijun Qian
Journal:  Expert Opin Ther Pat       Date:  2009-07       Impact factor: 6.674

10.  Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines.

Authors:  Jens E Ruhe; Sylvia Streit; Stefan Hart; Chee-Hong Wong; Katja Specht; Pjotr Knyazev; Tatjana Knyazeva; Liang Seah Tay; Hooi Linn Loo; Priscilla Foo; Winnie Wong; Sharon Pok; Shu Jing Lim; Huimin Ong; Ming Luo; Han Kiat Ho; Kaitian Peng; Tze Chuen Lee; Martin Bezler; Christian Mann; Silvia Gaertner; Heinz Hoefler; Stefano Iacobelli; Stephan Peter; Alice Tay; Sydney Brenner; Byrappa Venkatesh; Axel Ullrich
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

View more
  60 in total

Review 1.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

Review 2.  Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.

Authors:  Jonathan Welti; Sonja Loges; Stefanie Dimmeler; Peter Carmeliet
Journal:  J Clin Invest       Date:  2013-08-01       Impact factor: 14.808

3.  Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis.

Authors:  Rodolfo Villarreal-Calderon; Arturo Luévano-González; Mariana Aragón-Flores; Hongtu Zhu; Ying Yuan; Qun Xiang; Benjamin Yan; Kathryn Anne Stoll; Janet V Cross; Kenneth A Iczkowski; Alexander Craig Mackinnon
Journal:  Ann Diagn Pathol       Date:  2014-02-11       Impact factor: 2.090

Review 4.  Eph/ephrin signaling in the kidney and lower urinary tract.

Authors:  Anna-Carina Weiss; Andreas Kispert
Journal:  Pediatr Nephrol       Date:  2015-04-23       Impact factor: 3.714

5.  EPHB4 Protein Expression in Vascular Smooth Muscle Cells Regulates Their Contractility, and EPHB4 Deletion Leads to Hypotension in Mice.

Authors:  Yujia Wang; Eric Thorin; Hongyu Luo; Johanne Tremblay; Julie L Lavoie; Zenghui Wu; Junzheng Peng; Shijie Qi; Jiangping Wu
Journal:  J Biol Chem       Date:  2015-04-22       Impact factor: 5.157

6.  Genome-wide meta-analysis identifies novel loci associated with free triiodothyronine and thyroid-stimulating hormone.

Authors:  M Popović; A Matana; V Torlak; T Boutin; D Brdar; I Gunjača; D Kaličanin; I Kolčić; V Boraska Perica; A Punda; O Polašek; M Barbalić; C Hayward; T Zemunik
Journal:  J Endocrinol Invest       Date:  2019-03-07       Impact factor: 4.256

Review 7.  Ephrin ligands and Eph receptors contribution to hematopoiesis.

Authors:  Giovanna Tosato
Journal:  Cell Mol Life Sci       Date:  2017-06-06       Impact factor: 9.261

Review 8.  Mechanisms of endothelial cell migration.

Authors:  U Ruth Michaelis
Journal:  Cell Mol Life Sci       Date:  2014-07-20       Impact factor: 9.261

9.  Intersectin-1s: an important regulator of cellular and molecular pathways in lung injury.

Authors:  Dan N Predescu; Cristina Bardita; Rajive Tandon; Sanda A Predescu
Journal:  Pulm Circ       Date:  2013-12-05       Impact factor: 3.017

Review 10.  Molecular underpinnings of corneal angiogenesis: advances over the past decade.

Authors:  Nizar Saleh Abdelfattah; Mohamed Amgad; Amira A Zayed; Heba Hussein; Nawal Abd El-Baky
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.